OPEN CFDA 93.394 ↗ Competitive Cooperative Agreement Competitive ~100h typical effort

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

🏛 National Institutes of Health (HHS-NIH11)

✓ Free, no account · Source: Grants.gov · Last verified Oct 8, 2026

⏰ Deadline
Jan 25, 2027 in 108 days
📅 Fiscal Year
FY 2028
📍 Scope
National

Can you apply?

This grant is for research organizations conducting Small Cell Lung Cancer (SCLC) research through a coordinating center role. Eligible applicants typically include research institutions, universities, and medical centers with established research programs. The Coordinating Center manages shared resources, databases, biospecimen repositories, and provides administrative and scientific support to the SCLC Consortium. This is a single-source cooperative agreement, so eligibility may be limited to organizations meeting specific institutional criteria. Applicants must demonstrate capacity to coordinate multi-institutional research networks and maintain centralized research infrastructure.

Eligible applicants
Check your eligibility — what type of organization are you?

Not the right fit? Find grants for your organization in 5 questions →

Key dates

  1. Mar 24, 2026 Applications open
  2. Jan 25, 2027 Application deadline in 108 days
  3. Dec 1, 2027 Award announced
  4. Dec 1, 2027 Project start

Program description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to continue to support the Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium, which coordinates research on prevention, diagnosis, treatment, and mechanisms of resistance in SCLC. The CC manages administrative activities, centralized databases, tissue banking and a virtual biospecimen resource, biostatistics and bioinformatics support, in vivo and in vitro model repositories, and communications and website operations for the Consortium. Since its establishment in response to the Recalcitrant Cancer Research Act, the Consortium has catalyzed SCLC-focused research and enabled major advances in molecular characterization, tumor heterogeneity, microenvironment and immune evasion, biomarker development, preclinical models, therapeutic strategies, and clinical translation. The current U24 CC, based at Sloan Kettering with collaborating institutions, organizes meetings, maintains extensive -omics and model resources, supports young investigators, and provides datasets and models to the research community. The reissue NOFO will support a five-year cooperative agreement to sustain these shared resources and collaborations. This is a Forecast for a single source that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

Who can apply

Eligible applicants

How to apply

Application links

Key dates & requirements

  • ⏳ Project period: 60 months
  • 🧾 Budget narrative required. Free budget template →
  • 📅 Expected award date: Dec 1, 2027
  • 🚀 Project start date: Dec 1, 2027

Required documents

  • R&R (SF 424) Application Form
  • Project Narrative/Research Strategy
  • Budget and Budget Narrative
  • Biographical Sketches (Key Personnel)
  • Institutional Commitment and Support Letter
  • Letters of Collaboration from Partner Institutions
  • Data Management and Sharing Plan
  • Vertebrate Animal Use (if applicable)
  • Human Subjects Protection (if applicable)

Program contact

Funding track record

Recent awards under CFDA 93.394 from the last 3 years — real organizations that won funding through this same program.

89
awards (3 yrs)
$1.2B
total funded
48
unique recipients
$13.2M
average award

Top 10 Largest Recent Awards

  1. $75,651,803
  2. $62,505,795
  3. $42,615,772
  4. $42,479,238
  5. $41,104,414
  6. $39,877,109
  7. $37,552,767
  8. $35,037,695
  9. $32,779,637
  10. $29,069,762

Top States by Funding

  • CA 15 awards $184.3M
  • PA 10 awards $144.3M
  • OH 6 awards $137.8M
  • WA 7 awards $131.4M
  • MA 9 awards $99.6M

Source: USAspending.gov — federal spending transparency. Data covers last 3 years.

Funding history

Annual funding for this program — Federal obligations (CFDA 93.394). How funding has trended year over year.

2024 $540,918,671
2025 $602,293,691
2026 est. $716,748,079

FAQ

Who can apply for this Coordinating Center grant?

Research institutions and medical centers with strong SCLC research programs and capacity to coordinate multi-institutional efforts. Contact NCI for specific institutional eligibility criteria.

What is the deadline for this grant?

The deadline is January 25, 2027. This is a fixed deadline with no rolling submission period.

What are the main responsibilities of the Coordinating Center?

The CC manages databases, tissue banking, biospecimen resources, biostatistics support, model repositories, and consortium communications. It coordinates research activities across participating institutions.

How competitive is this funding opportunity?

This is a highly competitive single-source opportunity with peer review. Only meritorious applications will be funded.

Is this a clinical trial?

No, clinical trials are explicitly not allowed under this NOFO.

💡 Tips for applicants

  • Emphasize your institution's track record managing multi-institutional research networks and centralized resources.
  • Document existing infrastructure for databases, biospecimen banking, and bioinformatics support.
  • Highlight partnerships with collaborating institutions and demonstrate broad community engagement.
  • Detail specific plans for supporting young investigators and disseminating resources to the research community.
  • Show how your center will advance SCLC research in molecular characterization, therapeutic strategies, and clinical translation.

⚠️ Common mistakes

Underestimating the scope of coordinating center management responsibilities and overstating research capacity without proven infrastructure. Failing to demonstrate robust partnerships and collaborative relationships with other SCLC research institutions. Proposing activities that duplicate existing NCI resources rather than providing unique, complementary support to the research community.

Similar grants

Source: Grants.gov · FY 2028 · Last updated Aug 24, 2026

108 days left Jan 25, 2027
Apply →